Azaloxan
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
1-(1-{2-[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]ethyl}piperidin-4-yl)imidazolidin-2-one | |
| Identifiers | |
| CAS Number |
72822-56-1 86116-60-1 (fumarate) |
| ATC code | None |
| PubChem | CID 6328465 |
| ChemSpider |
4886586 |
| UNII |
0O653FA999 |
| ChEMBL |
CHEMBL2104648 |
| Chemical data | |
| Formula | C18H25N3O3 |
| Molar mass | 331.41 g/mol |
| |
| |
| | |
Azaloxan (CGS-7135A) is a drug which was patented as an antidepressant by Ciba-Geigy in the early 1980s, but was never marketed.[1]
Synthesis

Azaloxan synthesis: Ciba-Geigy, Charles F. Huebner; U.S. Patent 4,329,348 (1982).
- Allyl cyanide is starting material, and catechol.
See also
References
- ↑ David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, October 15, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
